By Scientia Professor Carla Treloar

Journal articles

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261

Treloar C; Hopwood M; Drysdale K; Lea T; Holt M; Dowsett GW; Aggleton P; Bryant J, 2021, 'Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex', International Journal of Drug Policy, 94, pp. 103229, http://dx.doi.org/10.1016/j.drugpo.2021.103229

Bryant J; Bolt R; Botfield JR; Martin K; Doyle M; Murphy D; Graham S; Newman CE; Bell S; Treloar C; Browne AJ; Aggleton P, 2021, 'Beyond deficit: ‘strengths-based approaches’ in Indigenous health research', Sociology of Health and Illness, 43, pp. 1405 - 1421, http://dx.doi.org/10.1111/1467-9566.13311

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore G; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571

Stardust Z; Treloar C; Cama E; Kim J, 2021, '‘I Wouldn’t call the cops if i was being bashed to death’: Sex work, whore stigma and the criminal legal system', International Journal for Crime, Justice and Social Democracy, 10, http://dx.doi.org/10.5204/IJCJSD.1894

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277

Drysdale K; Bryant J; Dowsett GW; Lea T; Treloar C; Aggleton P; Holt M, 2021, 'Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex.', Int J Drug Policy, 93, pp. 103163 - 103163, http://dx.doi.org/10.1016/j.drugpo.2021.103163

Madden A; Lancaster K; Ritter A; Treloar C, 2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, 87, pp. 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014

Miller K; Treloar C; Lloyd AR, 2021, 'People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?', Addiction Research and Theory, 29, pp. 247 - 254, http://dx.doi.org/10.1080/16066359.2021.1879058

Treloar C; Stardust Z; Cama E; Kim J, 2021, 'Rethinking the relationship between sex work, mental health and stigma: a qualitative study of sex workers in Australia', Social Science and Medicine, 268, http://dx.doi.org/10.1016/j.socscimed.2020.113468

Marshall AD; Hopwood M; Grebely J; Treloar C, 2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, 86, http://dx.doi.org/10.1016/j.drugpo.2020.102964

Reilly R; Gendera S; Treloar C; Roe Y; Conigrave K; Azzopardi P; Ward J, 2020, 'Identifying risk and protective factors, including culture and identity, for methamphetamine use in Aboriginal and Torres Strait Islander communities: Relevance of the ‘communities that care’ model', Social Science and Medicine, 266, http://dx.doi.org/10.1016/j.socscimed.2020.113451

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106

Broady TR; Brener L; Hopwood M; Cama E; Treloar C; Holt M, 2020, 'HIV stigma by association among Australian gay and bisexual men.', AIDS, 34 Suppl 1, pp. S53 - S62, http://dx.doi.org/10.1097/QAD.0000000000002565

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

Dore G; Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Mcmanus H; Butler T; Vickerman P; Martin N; Mchutchison J; Brainard D; Treloar C; Lloyd A, 2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, 73, pp. S127 - S127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587000206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Brener L; Broady T; Cama E; Hopwood M; de Wit JBF; Treloar C, 2020, 'The role of social support in moderating the relationship between HIV centrality, internalised stigma and psychological distress for people living with HIV', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 32, pp. 850 - 857, http://dx.doi.org/10.1080/09540121.2019.1659914

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15113

Drysdale K; Bryant J; Holt M; Hopwood M; Dowsett GW; Aggleton P; Lea T; Treloar C, 2020, 'Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use', International Journal of Drug Policy, 78, pp. 102697, http://dx.doi.org/10.1016/j.drugpo.2020.102697

Broady TR; Brener L; Cama E; Hopwood M; Treloar C, 2020, 'Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population', PLoS ONE, 15, pp. e0232218, http://dx.doi.org/10.1371/journal.pone.0232218

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Read P; Hajarizadeh B; Ezard N; Dore G; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Hopwood M; Cama E; de Wit J; Treloar C, 2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536

Gray R; Kelly PJ; Beck AK; Baker AL; Deane FP; Neale J; Treloar C; Hides L; Manning V; Shakeshaft A; Kelly J; Argent A; McGlaughlin R, 2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144

Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy, 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170

Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705

Stoové M; Wallace J; Higgs P; Pedrana A; Goutzamanis S; Latham N; Scott N; Treloar C; Crawford S; Doyle J; Hellard M, 2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C, 2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016

Bryant J; Rance J; Hull P; Mao L; Treloar C, 2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002

Walker M; Beadman K; Griffin S; Beadman M; Treloar C, 2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, 16, http://dx.doi.org/10.1186/s12954-019-0325-3

Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2019, 'Feasibility of a Mobile Health App for Routine Outcome Monitoring and Feedback in Mutual Support Groups Coordinated by SMART Recovery Australia: Protocol for a Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15113

Rhodes T; Lancaster K; Harris M; Treloar C, 2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475

Brener L; Cama E; Broady T; Hopwood M; de Wit J; Treloar C, 2019, 'Predictors of health care workers’ support for discriminatory treatment and care of people who inject drugs', Psychology, Health and Medicine, 24, pp. 439 - 445, http://dx.doi.org/10.1080/13548506.2018.1546018

Madden A; Hopwood M; Neale J; Treloar C, 2019, 'Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs', Patient, 12, pp. 259 - 265, http://dx.doi.org/10.1007/s40271-018-0332-6

Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J, 2019, 'Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs', International Journal of Drug Policy, 66, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.01.012

Treloar C; Pienaar K; Dilkes-Frayne E; Fraser S, 2019, 'Lives of Substance: a mixed-method evaluation of a public information website on addiction experiences', Drugs: Education, Prevention and Policy, 26, pp. 140 - 147, http://dx.doi.org/10.1080/09687637.2017.1397602

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Clark Y; Quinn B; Treloar C; Gray D; Dunlop A; Roe Y; Ward J, 2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, 21, http://dx.doi.org/10.2196/14084

Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013

Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J, 2019, 'Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework', Liver International, 39, pp. 20 - 30, http://dx.doi.org/10.1111/liv.13949

Broady TR; Cama E; Brener L; Hopwood M; de Wit J; Treloar C, 2018, 'Responding to a national policy need: development of a stigma indicator for bloodborne viruses and sexually transmissible infections', Australian and New Zealand Journal of Public Health, 42, pp. 513 - 515, http://dx.doi.org/10.1111/1753-6405.12809

Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987

Levy M; Treloar C, 2018, 'Health protection and Australian prisons, 2018', The Medical Journal of Australia, 209, pp. 460 - 461, http://dx.doi.org/10.5694/mja18.00669

Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011

Back to profile page